Fstradio.com
Fstradio.com
 
 
 
 
News

Merck and C Sixty

Merck and C Sixty to pursue fullerene antioxidant technology - In the field: pharmaceutical science & technology newsMerck and Co. (Whitehouse Station, NJ) has entered into an agreement with the biotechnology company C Sixty (Houston, TX) for the development and commercialization of C Sixty's fullerene antioxidant technology.

Universities and FDA

Universities and FDA collaborate to reduce cost of manufacturing - In the field: Pharmaceutical Science & Technology newsThe top 16 U.S. pharmaceutical companies spend more than $90 billion on manufacturing each year, according to a Wall Street Journal article released 3 September 2003.

EU to provide

EU to provide incentives for "orphan" drugs - NewsThe European Union has introduced new legislation designed to encourage pharmaceutical companies to develop treatments for "orphan" (rare) diseases that affect fewer than five people in every 10000 within the 15 member bloc.

The happiness

The happiness industry: there are big profits in claiming to make people happy. But are those who seek well-being from therapy, drugs and self-help books being ripped off?We know that money doesn't buy happiness. But the search for happiness is certainly enriching a lot of people. The feel-good industry is flourishing.

Pharmaceutical industry issues its plan for voluntary clinical trials registry In the face of bad publicity and impending restrictions, trade groups representing pharmaceutical companies have proposed a voluntary plan for using a clinical trials registry as well as results databases by midyear.

» more

Toxic treasure: poisons and venoms from deadly animals could become tomorrow's miracle drugs. And few places on Earth harbor so many deadly animals as Australia's Great Barrier Reef [Australia] has more things that will kill you than anywhere else.... This is a country where even the fluffiest of caterpillars can lay you out with a toxic nip, where seashells will not just sting you but actually sometimes gofer you.... It's a tough place.

» more

Optimism taking over in pharmaceutical chemicals: after a five-year downturn, cautious optimism is taking hold among API manufacturers The mood among exhibitors at this year's Informex trade show in Las Vegas was the brightest it has been in several years. Although 2005 looks like it will deliver slight improvement from the ugliness of the first years of the decade, manufacturers of active pharmaceutical ingredients (APIs) are looking for a return to real profitability in 2006.

» more

Naming, classification, and trademark selection: Implications for market success of pharmaceutical products Even though trademark legislation does not specifically address the needs of the pharmaceutical industry, there are unique rules governing the nomenclature, nonproprietary naming, and trademark choice of pharmaceuticals.

» more